At Takeda, we are committed to advancing access to innovative medical treatments and to supporting social initiatives that work to reduce gaps in healthcare services and improve the lives of patients.
As a company with more than 240 years of history, we invest significant resources in the fields of gastroenterology, immunology, oncology, rare diseases, and plasma-derived therapies—recognizing that for these patients, every day truly matters.
We believe that collaboration between the business, public, and social sectors is key to creating meaningful impact for patients who need it most. Our commitment is to work in partnership with decision-makers and the healthcare system to reduce gaps in both time and access to treatment. Our collaboration with Haverim L’Refuah reflects shared values of mutual responsibility, social responsibility, and a deep commitment to patients. We commend Haverim L’Refuah for its important and impactful work.
Arie Kramer
CEO, Takeda Israel & Chair, Pharma Israel
